NewsBenzinga月曜日に報告された、バルネバがFDAの中止と新たな重大な有害事象の審査に続き、米国でのIXCHIQチクングンヤワクチンのBLAおよびINDを取り下げます。 月曜日に報告された、バルネバがFDAの中止と新たな重大な有害事象の審査に続き、米国でのIXCHIQチクングンヤワクチンのBLAおよびINDを取り下げます。 Benzinga 2026.01.21 04:40 (GMT+0) Open on Benzinga 共有 Facebook Twitter LinkedIn Pinterest Email 同社は米国でのIXCHIQ BLAおよびINDを自主的に撤回 医療ニーズと商業的魅力に応じて、世界的な製品の可能性についての検討を継続 Other news Keybanc Downgrades BILL Holdings to Sector Weight William Blair Upgrades Pyxis Oncology to Outperform BTIG Reiterates Buy on Walmart, Maintains $140 Price Target Procter & Gamble Plans up to 30% Supply Job Cuts by 2030, Aims for $10 Billion in Cost Savings Mark Cuban Says Healthcare Economics Run On ‘Contractual Terrorism’: ‘Even the Biggest Companies Get Ripped Off’ Hewlett Packard Enterprise Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Mark Cuban Says Healthcare Economics Run On ‘Contractual Terrorism’: ‘Even the Biggest Companies Get Ripped Off’
Hewlett Packard Enterprise Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call